(b)(4).No reported significant delay to procedure, patient consequence or harm.Blushing/bleeding was repaired with application of bioglue and patient reported as stable post op.(b)(4).Information from the customer indicated that the device was not rinsed in saline for 5 minutes prior to use.(b)(4).Ifu states that failure to rinse for 5 minutes could lead to the graft being more susceptible to leakage when implanted.A 5-year review of previous complaints was carried out and gave an occurrence rate of (b)(4) (complaints v sales) across all gelweave products and leakage types and (b)(4) (complaints v sales) for blushing only.Review of retained qc, manufacturing and physical testing records performed: a review of retained qc and manufacturing records showed that this batch was manufactured to specification with no issues raised.A review of the graft base material physical tests showed all testing met acceptance criteria.Base material porosity tests and finished product porosity tests were all within specification with no issues highlighted.Device not accessible for testing: device remains implanted in patient and will not be returned for testing.Review of product batch records showed no issue with the manufacture of this batch.From the information received, users failure to rinse the device for 5 mins prior to the procedure as stated in gelsoft plus ifu may have contributed to the leakage seen.Vascutek ltd, now considers this complaint closed.Further action is not planned, however, the issue will be tracked and trended.
|
Event was reported to vascutek ltd.As follows: oozing blood from the graft at aortic arch.Short video was provided showing heavy blushing of the graft between proximal anastamosis, and branches of arch.There is little or no bleeding from the remaining arch, or branches of the device.
|